Bal Pharma Limited, a Bangalore based company specializes in API, Intermediates and Finished Formulations. We have 6 state-of-the-art manufacturing facilities approved by various international regulatory bodies and supply products to more than 60 countries. We are one of the leading manufacturers of Gliclazide API in the world. We have filed Bepotastine API with US FDA. We also possess COS, Canadian, Japanese, Korean, European DMF’s for Glicalzide & Ebastine with fillings in pipeline viz Amiloride, Tolterodine Tartrate, Benzydamine HCl and Topiramate. We have over 200 Finished Formulations of various therapeutic segments. We offer an extensive range of products covering tablets, capsules, syrups, suspensions, IV infusions, creams and ointments in different therapeutic segments. We have received EU GMP approval for the formulation facility and are looking for the partners to associate with Regulated markets. For further details, visit us at www.balpharma.com
Looking for a particular Bal Pharma Limited employee's phone or email?
The Bal Pharma Limited annual revenue was $35.9 million in 2026.
Bharath V is the CFO of Bal Pharma Limited.
559 people are employed at Bal Pharma Limited.
Bal Pharma Limited is based in Bangalore, Karnataka.
The NAICS codes for Bal Pharma Limited are [32, 32541, 325, 3254].
The SIC codes for Bal Pharma Limited are [283, 28].